Niva Bupa Health Insurance (NIVABUPA) Fundamentals 2026 — P/E 119.4x, Revenue Analysis | SniperIQ
Niva Bupa Health Insurance (NIVABUPA) is a India-listed Financial Services company in Insurance - Life with a market capitalization of ₹15,680 Crore, trading at ₹84.79 on the NSE. This SniperIQ fundamentals page covers Niva Bupa Health Insurance's valuation (P/E 119.4x, P/B 4.9x), profitability (net margin 2.0%), revenue (₹6,695 Crore in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Niva Bupa Health Insurance's market cap?
Niva Bupa Health Insurance (NIVABUPA) has a market capitalization of approximately ₹15,680 Crore, trading at ₹84.79 on the NSE. Market cap moves with the live share price.
What is Niva Bupa Health Insurance's P/E ratio?
Niva Bupa Health Insurance's trailing twelve-month P/E ratio is 119.4x, with a price-to-book (P/B) of 4.9x. Valuation multiples are best compared with Financial Services sector peers rather than read in isolation.
How profitable is Niva Bupa Health Insurance?
Niva Bupa Health Insurance runs a net profit margin of 2.0%, a gross margin of 64.9%, and an operating margin of 2.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Niva Bupa Health Insurance generate?
Niva Bupa Health Insurance reported revenue of ₹6,695 Crore for fiscal year 2025, with net income of ₹131 Crore and earnings per share (EPS) of 0.71. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Niva Bupa Health Insurance pay a dividend?
Niva Bupa Health Insurance does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Niva Bupa Health Insurance financially healthy?
Niva Bupa Health Insurance carries a debt-to-equity ratio of 0.08x and a current ratio of 0.00x, with a market beta of 0.48. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Niva Bupa Health Insurance a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Niva Bupa Health Insurance (NIVABUPA) the key facts are: market cap ₹15,680 Crore, P/E 119.4x, revenue ₹6,695 Crore, 52-week range 67.5-91.2. Weigh valuation, profitability, growth, and balance-sheet strength against Financial Services peers and form your own view.
Track Niva Bupa Health Insurance's full fundamentals live
Get Niva Bupa Health Insurance's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.